Intratumoral CAN1012(selective TLR7 Agonist) in Subjects with Solid Tumors
Clinical trial NCT05580991 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05580991
- Sponsor
- Canwell Biotech Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-09
- Primary completion
- 2025-06-30
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.